ARCHIVES

New Center Plan Discussed By NAB, Directors Committees

This article is from The Cancer Letter archive.

Vol. 16 No. 18 | May 4, 1990

Download PDF Visit The Full Archive

Related Articles

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

Gallo Publishes Study to Resolve controversy Over HIV Discovery

March 15, 1991